Press Resease

Hereditary Cancer Testing Market - Global Industry Analysis

Hereditary Cancer Testing Market by Diagnosis Type (Biopsy, Imaging and Others), By End-User (Hospitals, Clinics, and Diagnostic Centers), and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Published Date: 07-Aug-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3262 Status : Published

Global hereditary cancer testing market expected to generate revenue of around USD 147.62 billion by end of 2024, growing at a CAGR of around 6% between 2018 and 2024. Hereditary cancer testing is a process that identifies an inherited gene mutation that increases the risk of cancer development. Hereditary cancer testing majorly covers predictive genetic testing and clinical DNA sequencing.

Description

The report covers forecast and analysis for the hereditary cancer testing market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hereditary cancer testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hereditary cancer testing market on a global level.

In order to give the users of this report a comprehensive view of the hereditary cancer testing market, we have included competitive landscape and analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, where diagnosis type, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hereditary Cancer Testing Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market in global and regional basis.

The study provides a decisive view of the hereditary cancer testing market by segmenting the market based on diagnosis type, end-user, and regions. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024.

Based on diagnosis type, the hereditary cancer testing market is segmented as biopsy, imaging, and others. Based on end-user, the hereditary cancer testing market is segmented as hospitals, clinics, and diagnostic centers.

Growing demand for non-invasive techniques for detection of hereditary cancer coupled with government funding for improvement of rapid diagnostics and rising concerns of hereditary cancer are the major driving factors of hereditary cancer testing market. Difficulties in accessing the complete genomic data for early detection and prevention will influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Germany, France, U.K., China, Japan, India, and Brazil. This segment includes demand for hereditary cancer testing market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Myriad Genetics, Myogenes, Laboratory Corporation of America, Biocartis NV, Quest Diagnostics, Pathway Genomics, Invitae Corporation, and Strand Life Sciences Pvt. Ltd., among others.

This report segments the global hereditary cancer testing market as follows:

Global Hereditary Cancer Testing Market: by Diagnosis Type

  • Biopsy
  • Imaging
  • Others

Global Hereditary Cancer Testing Market: by End-User Channel

  • Hospitals
  • Clinics
  • Diagnostic Centers

Global Hereditary Cancer Testing Market: by Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Hereditary Cancer Testing Market, 2015 - 2024 (USD Billion)
    • 2.2. Global Hereditary Cancer Testing Market: Snapshot
  •  
  • Chapter 3. Hereditary Cancer Testing Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Hereditary Cancer Testing Market drivers: Impact analysis
      • 3.2.2. Swelling demand for non-invasive techniques for detection of hereditary cancer
      • 3.2.3. Increasing government funding for improvement of rapid diagnostics
    • 3.3. Market Restraints
      • 3.3.1. Difficulties in accessing the complete genomic data for early detection and prevention
    • 3.4. Opportunities
      • 3.4.1. Inevitable need of avoiding cancer
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Diagnosis Type
      • 3.6.2. Market attractiveness analysis, by End-User
      • 3.6.3. Market attractiveness analysis, by Regional Segment
  •  
  • Chapter 4. Global Hereditary Cancer Testing Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Hereditary Cancer Testing Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Diagnosis Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Hereditary Cancer Testing Market - Diagnosis Type Segment Analysis
    • 5.1. Global Hereditary Cancer Testing Market: Diagnosis Type overview
      • 5.1.1. Global Hereditary Cancer Testing Market revenue share, by Diagnosis Type, 2015 and 2024(USD Billion)
    • 5.2. Biopsy
      • 5.2.1. Global Biopsy market, 2015 - 2024(USD Billion)
    • 5.3. Imaging
      • 5.3.1. Global Imaging market, 2015 - 2024(USD Billion)
    • 5.4. Others
      • 5.4.1. Global Others market, 2015 - 2024(USD Billion)
  •  
  • Chapter 6. Global Hereditary Cancer Testing Market - End-User Channel Segment Analysis
    • 6.1. Global Hereditary Cancer Testing Market: End-User Channel overview
      • 6.1.1. Global Hereditary Cancer Testing Market revenue share, by End-User Channel, 2014 and 2024(USD Billion)
    • 6.2. Hospitals
      • 6.2.1. Global Hereditary Cancer Testing Market for Hospitals, 2015 - 2024(USD Billion)
    • 6.3. Clinics
      • 6.3.1. Global Hereditary Cancer Testing Market for Clinics, 2015 - 2024(USD Billion)
    • 6.4. Diagnostic Centers
      • 6.4.1. Global Hereditary Cancer Testing Market for Diagnostic Centers, 2015 - 2024(USD Billion)
  •  
  • Chapter 7. Global Hereditary Cancer Testing Market - Regional Segment Analysis
    • 7.1. Global Hereditary Cancer Testing Market: Regional overview
      • 7.1.1. Global Hereditary Cancer Testing Market revenue share, by Region, 2015 and 2024
    • 7.2. North America
      • 7.2.1. North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
      • 7.2.2. North America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 7.2.3. North America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.2.4.2. The U.S. Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.2.4.3. The U.S. Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.2.5.2. Rest of North America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.2.5.3. Rest of North America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
      • 7.3.2. Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 7.3.3. Europe Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.3.4.2. Germany Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.3.4.3. Germany Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.5. U.K.
        • 7.3.5.1. U.K. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.3.5.2. U.K. Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.3.5.3. U.K. Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.3.6.2. France Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.3.6.3. France Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.3.7.2. Rest of Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.3.7.3. Rest of Europe Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
      • 7.4.2. Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 7.4.3. Asia Pacific Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.4.4.2. China Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.4.4.3. China Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.4.5.2. Japan Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.4.5.3. Japan Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.4.6.2. India Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.4.6.3. India Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.4.7.3. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
      • 7.5.2. Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 7.5.3. Latin America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.5.4.2. Brazil Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.5.4.3. Brazil Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
        • 7.5.5.2. Rest of Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
        • 7.5.5.3. Rest of Latin America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
      • 7.6.2. The Middle East and Africa Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
      • 7.6.3. The Middle East and Africa Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Myriad Genetic
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Myogenes
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Laboratory Corporation of America
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Biocartis NV
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Quest Diagnostics
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Pathway Genomics
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Invitae Corporation
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Strand Life Sciences Pvt. Ltd.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments

List of Figures 

1. Market research process
2. Market research methodology
3. Global Hereditary Cancer Testing Market revenue, 2015 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Hereditary Cancer Testing Market attractiveness analysis, by Diagnosis Type segment
6. Hereditary Cancer Testing Market attractiveness analysis, by End-User segment
7. Hereditary Cancer Testing Market: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015 
9. Global Hereditary Cancer Testing Market revenue share by Diagnosis Type, 2014 and 2022
10.  Global Hereditary Cancer Testing Market, 2015 – 2024 (USD Billion)

  • a. Global Biopsy market, 2015 – 2024(USD Billion)
  • b. Global Imaging market, 2015 – 2024(USD Billion)
  • c. Global Others market, 2015 – 2024(USD Billion)

11. Global Hereditary Cancer Testing Market revenue share by End-User, 2014 and 2022
12. Global Hereditary Cancer Testing Market, 2015 – 2024 (USD Billion)

  • a. Hospitals, 2015 – 2024(USD Billion)
  • b. Clinics, 2015 – 2024(USD Billion)
  • c. Diagnostic Centers, 2015 – 2024(USD Billion)

List of Tables

1. Hereditary Cancer Testing Market: Market snapshot                                                                                  
2. Drivers of global Hereditary Cancer Testing Market: Impact analysis 
3. Restraints of Hereditary Cancer Testing Market: Impact analysis  
4. North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
5. North America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
6. North America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
7. The U.S. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
8. The U.S. Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
9. The U.S. Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
10. Rest of North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
11. Rest of North America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
12. Rest of North America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
13. Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
14. Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
15. Europe Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
16. Germany Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
17. Germany Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
18. Germany Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
19. U.K. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
20. U.K. Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
21. U.K. Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
22. France Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
23. France Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
24. France Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
25. Rest of Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
26. Rest of Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
27. Rest of Europe Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
28. Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
29. Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
30. Asia Pacific Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
31. China Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
32. China Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
33. China Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
34. Japan Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
35. Japan Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
36. Japan Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
37. India Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
38. India Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
39. India Hereditary Cancer Testing Market revenue, by region, 2015 – 2024(USD Billion)
40. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
41. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
42. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
43. Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
44. Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)  
45. Latin America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
46. Brazil Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
47. Brazil Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
48. Brazil Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion) 
49. Rest of Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
50. Rest of Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion) 
51. Rest of Latin America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
52. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion) 
53. The Middle East and Africa Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)  
54. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion) 

Methodology

Free Analysis

Cancer takes place due to an inherited mutation called as hereditary cancer. Hereditary cancer testing is a process that identifies an inherited gene mutation that increases the risk of cancer development. Hereditary cancer testing majorly covers predictive genetic testing and clinical DNA sequencing. In predictive genetic testing, the patient’s family history is analyzed for inherited mutation from ancestry. It is useful for testing many genetic mutations at a time.
Hereditary cancer testing is similar to other cancer testings and it includes lab tests, imaging procedures, and biopsy. This test does not diagnose whether a person is suffering from cancer it only recognizes if a person is bearing a change in genes which increases the risk of cancer.

Growing demand for non-invasive techniques for detection of hereditary cancer is the major driver of the hereditary cancer testing market. According to CDC (Centers for Disease Control and Prevention), over 200,000 women in the U.S. are diagnosed with breast cancer and more than 20,000 are diagnosed with ovarian cancer each year. Whereas, 3% of breast cancer and 10% of ovarian cancer are caused due to inherited mutations. Ovarian cancer, pancreatic cancer, bowel cancer, breast cancer, kidney cancer, thyroid cancer, melanoma, prostate cancer, retinoblastoma, womb cancer, and other types of cancer are tested by using hereditary cancer testing. In addition to the increased requirement for non-invasive techniques for discovery of hereditary cancer, growing government funding for improvement of rapid diagnostics, and concerns related hereditary cancer are also resulting in increased demand for hereditary cancer testing market. The inevitable need for avoiding cancer in coming future is likely to boost the demand for hereditary cancer testing market in the coming years. As the demand for non-invasive techniques is increasing histopathological detection still acts as a golden standard for identification of hereditary cancer.

Global Hereditary Cancer Testing Market

The hereditary cancer testing market is classified based on diagnosis type, end-user, and region. On the basis of the diagnosis type, the market is divided into imaging, biopsy, and others. On the basis of the end-user, the market is segmented as diagnostic centers, hospitals, and clinics. Increasing number of cancer patients and the growing severity of hereditary cancer are the major factors responsible for the expansion of the global hereditary cancer testing market. Factors responsible for the expansion of global hereditary testing market are worldwide increasing cancer patients and severity of hereditary cancer.

By geography, North America dominates the hereditary cancer testing market due to the high prevalence of cancer among the population coupled with presence of many dominant players located in the U.S. Emerging regions such as the Asia Pacific is also experiencing a major outbreak due to raising awareness among people about cancer, which is projected to offer several opportunities to the hereditary cancer testing market. These all factors are likely to drive the Asia Pacific market in the near future. Latin America and the Middle East and Africa is another key regional market and is expected to grow moderately in the coming years owing to rising healthcare infrastructure, increasing awareness among the people, and changing government policies in these regions. 

Some of the key players in the hereditary cancer testing market include Myriad Genetics, Myogenes, Laboratory Corporation of America, Biocartis NV, Quest Diagnostics, Pathway Genomics, Invitae Corporation, and Strand Life Sciences Pvt. Ltd., among others. 
 

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social